AVDL - Avadel Pharmaceuticals GAAP EPS of -$0.30 misses by $0.29 revenue of $27.18M beats by $1.28M
2024-05-08 07:49:55 ET
More on Avadel Pharmaceuticals plc
- Avadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolution
- Avadel Pharmaceuticals: Robust Launch Of Lumryz And Eased Litigation Overhang
- Avadel surges after royalty rate awarded to Jazz in patent dispute lower than requested (update)